Evidence map›Paper›PMID 38991026›Full record

ArticlePLoS pathogens2024

Clinical and in vitro models identify distinct adaptations enhancing Staphylococcus aureus pathogenesis in human macrophages.

Dustin R Long, Elizabeth A Holmes, Hsin-Yu Lo, Kelsi Penewit, Jared Almazan, Taylor Hodgson, Nova F Berger, Zoe H Bishop, Janessa D Lewis, Adam Waalkes and 2 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Dustin R LongDivision of Critical Care Medicine, Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America.
Elizabeth A HolmesDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Hsin-Yu LoDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Kelsi PenewitDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Jared AlmazanDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Taylor HodgsonDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Nova F BergerDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Zoe H BishopDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Janessa D LewisDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Adam WaalkesDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Daniel J WolterDepartment of Pediatrics, University of Washington School of Medicine, Seattle, Washington, United States of America.
Stephen J SalipanteDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America.ORCID 0000-0001-8355-6992

Funding

Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss, Lucas R Hoffman · 2010 to 2026
$21.4M
Targeting the Patient Microbiome for the Prevention of Surgical Site Infection in Spine SurgeryK23AR080209 · NIAMS · UNIVERSITY OF WASHINGTON · PI Dustin R Long · 2022 to 2026
$833k
NIAMS NIH HHS K23 AR080209NIAMS NIH HHS L30 AR079800NIDDK NIH HHS P30 DK089507
6 · The paper itself

Abstract

Staphylococcus aureus is a facultative intracellular pathogen of human macrophages, which facilitates chronic infection. The genotypes, pathways, and mutations influencing that phenotype remain incompletely explored. Here, we used two distinct strategies to ascertain S. aureus gene mutations affecting pathogenesis in macrophages. First, we analyzed isolates collected serially from chronic cystic fibrosis (CF) respiratory infections. We found that S. aureus strains evolved greater macrophage invasion capacity during chronic human infection. Bacterial genome-wide association studies (GWAS) identified 127 candidate genes for which mutation was significantly associated with macrophage pathogenesis in vivo. In parallel, we passaged laboratory S. aureus strains in vitro to select for increased infection of human THP-1 derived macrophages, which identified 15 candidate genes by whole-genome sequencing. Functional validation of candidate genes using isogenic transposon mutant knockouts and CRISPR interference (CRISPRi) knockdowns confirmed virulence contributions from 37 of 39 tested genes (95%) implicated by in vivo studies and 7 of 10 genes (70%) ascertained from in vitro selection, with one gene in common to the two strategies. Validated genes included 17 known virulence factors (39%) and 27 newly identified by our study (61%), some encoding functions not previously associated with macrophage pathogenesis. Most genes (80%) positively impacted macrophage invasion when disrupted, consistent with the phenotype readily arising from loss-of-function mutations in vivo. This work reveals genes and mechanisms that contribute to S. aureus infection of macrophages, highlights differences in mutations underlying convergent phenotypes arising from in vivo and in vitro systems, and supports the relevance of S. aureus macrophage pathogenesis during chronic respiratory infection in CF. Additional studies will be needed to illuminate the exact mechanisms by which implicated mutations affect their phenotypes.

Indexed as

Cystic FibrosisGenome-Wide Association StudyMacrophagesStaphylococcal InfectionsStaphylococcus aureusAdaptation, PhysiologicalHumansMutationVirulenceVirulence FactorsVirulence Factors

Identifiers

PMID38991026
PMCPMC11265673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.